Business Segments BGI Genomics Co., Ltd.
Equities
300676
CNE100003449
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.95 CNY | +1.64% | -0.56% | -7.20% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Medical Labs & Research | 2.8B | 8.4B | 6.77B | 7.05B | 4.35B | |||||
Total Assets | 5.91B | 11.2B | 14.25B | 14.38B | 13.61B | |||||
Interest Expense | -5.73M | -89.04M | -105M | -101M | -91.56M | |||||
Income Tax Expense | 49.67M | 340M | 268M | 198M | 21.85M | |||||
CAPEX | -626M | -301M | -384M | -1.27B | -1.24B | |||||
EBT | 328M | 2.44B | 1.75B | 1.01B | 116M | |||||
D&A | 239M | 299M | 363M | 441M | 419M | |||||
Operating Income | 330M | 2.5B | 1.82B | 1.09B | 151M | |||||
Net Income | 276M | 2.09B | 1.46B | 803M | 92.9M |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Mainland China (Excluding Hong Kong, Macau and Taiwan) | 2.34B | 2.8B | 2.88B | 3.62B | 3.46B | |||||
Total Assets | 1.33B | 1.27B | 1.49B | 2.47B | 3.63B | |||||
Asia (Including China, Hong Kong, Macau, and Taiwan) and Oceania | 144M | 3.78B | 2.51B | 2.79B | 558M | |||||
Total Assets | - | - | 207M | - | 197M | |||||
Total Assets | 204M | 183M | - | 185M | - | |||||
Total Assets | 7.8M | 17.98M | - | 17.49M | - | |||||
Total Assets | 24.26M | 55.02M | - | 137M | - | |||||
Europe and Africa | 193M | 990M | 939M | 389M | 217M | |||||
Total Assets | - | - | 113M | - | 116M | |||||
Americas | 127M | 833M | 432M | 245M | 116M | |||||
Total Assets | - | - | 9.92M | - | 24.28M | |||||
North and South America | - | - | - | - | - | |||||
Asian-Pacific | - | - | - | - | - | |||||
China | - | - | - | - | - |
- Stock Market
- Equities
- 300676 Stock
- Financials BGI Genomics Co., Ltd.
- Business Segments